Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NORRIS MEDI. Plunges 5%; BSE HEALTHCARE Index Down 1.0%
Thu, 17 Oct 13:58

NORRIS MEDI. Plunges 5%; BSE HEALTHCARE Index Down 1.0%Image source: CreativaImages/www.istockphoto.com

NORRIS MEDI. share price has plunged 5% and is presently trading at Rs 18.8.

Meanwhile, the BSE HEALTHCARE index is at 44,202.6 (down 1.0%).

Among the top losers in the BSE HEALTHCARE index today are Jubilant Pharmova (down 3.2%) and LAURUS LABS (down 2.5%).

Pfizer (up 1.6%) and SUVEN PHARMACEUTICALS (up 1.3%) are among the top gainers today.

Over the last one year, NORRIS MEDI. has moved up from Rs 11.5 to Rs 18.8, registering a gain of Rs 7.3 (up 63.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,202.6, registering a gain of 56.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 192.9%), Glenmark Pharma (up 120.0%) and SUVEN PHARMACEUTICALS (up 115.0%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,009.5 (down 0.6%).

The top losers among the BSE Sensex today are Ultratech Cement (down 3.4%) and M&M (down 3.2%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..

In the meantime, NSE Nifty is at 24,753.8 (down 0.9%). Bajaj Auto and Shriram Transport are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,009.5, registering a gain of 14,842.5 points (up 22.4%).

NORRIS MEDI. Financial Update...

NORRIS MEDI. net profit grew 40.5% YoY to Rs -4 million for the quarter ended June 2024, compared to a loss of Rs 6 million a year ago. Net sales declined 23.4% to Rs 7 million during the period as against Rs 9 million in April-June 2023.

For the year ended March 2023, NORRIS MEDI. reported 46.4% increase in net profit to Rs -17 million compared to net loss of Rs 33 million during FY22. Revenue of the company fell 11.4% to Rs 84 million during FY23.

The current Price to earnings ratio of NORRIS MEDI., based on rolling 12 month earnings, stands at -20.0.


Equitymaster requests your view! Post a comment on "NORRIS MEDI. Plunges 5%; BSE HEALTHCARE Index Down 1.0%". Click here!